PepGen Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| Viking | long/short | 3.48M | $6.16M | 0.02% | Unchanged | 2026-03-31 |
| StateStreet | passive | 229.4K | $406.02K | 0.00% | Added+5.5% | 2026-03-31 |
| TwoSigma | quant | 181.7K | $321.62K | 0.00% | Trimmed-32.1% | 2026-03-31 |
| Wellington | fundamental | 122.0K | $215.89K | 0.00% | New | 2026-03-31 |
| Citadel | multi-strat | 66.0K | $116.77K | 0.00% | Trimmed-97.1% | 2026-03-31 |
| RenTech | quant | 56.8K | $100.54K | 0.00% | Trimmed-61.6% | 2026-03-31 |
| FidelityFMR | fundamental | 1.7K | $2.94K | 0.00% | Unchanged | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-13upcoming | -0.29 | — | — |
| 2026-03-04 | -0.39 | -0.27 | +31.47% |
| 2025-11-12 | -0.56 | -0.52 | +7.96% |
| 2025-08-07 | -0.86 | -0.70 | +18.92% |
| 2025-05-08 | -0.75 | -0.92 | -22.67% |
| 2025-02-24 | -0.72 | -0.68 | +5.56% |
| 2024-11-07 | -0.77 | -0.66 | +14.29% |
| 2024-08-08 | -0.68 | -0.87 | -27.01% |
| 2024-05-14 | -0.64 | -0.63 | +1.56% |
| 2024-03-06 | -0.95 | -0.81 | +15.18% |
| 2023-11-08 | -0.80 | -0.98 | -21.74% |
| 2023-08-08 | -0.75 | -0.82 | -9.33% |
| 2023-05-11 | -0.74 | -0.69 | +6.76% |
| 2023-03-23 | -0.91 | -0.24 | +73.63% |
| 2022-11-10 | -1.00 | -0.79 | +21.26% |
| 2022-08-12 | -0.76 | -1.23 | -61.84% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| PEPG | -14.29% | -76.64% | -76.96% | +2.74% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -17.25% | -72.00% | -73.52% | -9.95% |